Financial

Global Vertebral Compression Fractures Devices Market Expected to Reach $1,109 Million by 2022
Financial Spine

Global Vertebral Compression Fractures Devices Market Expected to Reach $1,109 Million by 2022

Press release from: Allied Market Research – March 06,2017 Vertebral Compression Fracture Devices Market Report, published by Allied Market Research, forecasts that the global market was valued at $748 million in 2015, and is expected to reach $1,109 million by 2022, supported by a CAGR of 5.7% during the forecast period […]

Medovex Corporation Regains Compliance With Nasdaq Minimum Stockholders’ Equity Listing Requirement
Financial

Medovex Corporation Regains Compliance With Nasdaq Minimum Stockholders’ Equity Listing Requirement

ATLANTA, GA–(Marketwired – Mar 2, 2017) – Medovex Corp. (NASDAQ: MDVX), a developer of medical technology products, today announced that on March 1, 2017, Nasdaq issued a determination that the company has evidenced compliance with the minimum $2.5 million stockholders’ equity requirement for continued listing on The Nasdaq Capital Market. […]

Cellular Biomedicine Group Awarded $2.29 Million Grant from the California Institute for Regenerative Medicine (CIRM)
Biologics Financial

Cellular Biomedicine Group Awarded $2.29 Million Grant from the California Institute for Regenerative Medicine (CIRM)

SHANGHAI, China and CUPERTINO, Calif., Feb. 27, 2017 (GLOBE NEWSWIRE) — Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in the development of effective immunotherapies for cancer and stem cell therapies for degenerative diseases, announced today that the governing Board of the California Institute for […]

Orthofix International Reports Fourth Quarter and Fiscal 2016 Financial Results
Financial

Orthofix International Reports Fourth Quarter and Fiscal 2016 Financial Results

February 27, 2017 LEWISVILLE, Texas–(BUSINESS WIRE)– Orthofix International N.V. (OFIX) today reported its financial results for the fourth quarter and fiscal year ended December 31, 2016. For the fourth quarter of 2016, net sales were $108.5 million, loss per share from continuing operations was ($0.29) and adjusted earnings per share from continuing […]

High-Quality Low-Cost Patient Care: Why the ASC Model May Well Represent the Future of Healthcare Providers in the US?
Financial Top Stories

High-Quality Low-Cost Patient Care: Why the ASC Model May Well Represent the Future of Healthcare Providers in the US?

February 23, 2017 – By David Hamilton and Devin Jenkins, MHA The major challenge dominating the healthcare industry has always been to lower the cost of patient care while not sacrificing quality. As technology continues to advance in surgery, more procedures can be done outside a traditional hospital setting (such as […]

Integra LifeSciences Announces Acceptance of Shares Tendered into Offer for Derma Sciences, Inc.
Financial

Integra LifeSciences Announces Acceptance of Shares Tendered into Offer for Derma Sciences, Inc.

PLAINSBORO, N.J., Feb. 23, 2017 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (“Integra”) (NASDAQ:IART), a global leader in medical technology, announced today that its tender offer by its wholly-owned subsidiary, Integra Derma, Inc. (“Offeror”), to purchase all outstanding common and preferred shares of Derma Sciences, Inc. (“Derma Sciences”) (NASDAQ:DSCI) at […]

Integra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results
Financial

Integra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results

PLAINSBORO, N.J., Feb. 23, 2017 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ:IART) today reported its financial results for the fourth quarter and full year ending December 31, 2016. Highlights: Full-year 2016 revenue increased 12.4% to $992.1 million, while organic revenue increased 9.0% over the prior year; Fourth quarter revenue increased 6.0% […]

MiMedx Announces 2016 Record Results
Financial

MiMedx Announces 2016 Record Results

MARIETTA, Ga., Feb. 23, 2017 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, today announced its record […]